Table 1 Study Demographics
Total (N = 1177) | Survivors (N = 1018) | Non-long term Survivor (N = 159) | P-value | |
|---|---|---|---|---|
Male (%) | 939 (80%) | 823(81%) | 116 (73%) | P = 0.026 |
female (%) | 238 (20%) | 195(19%) | 43 (27%) | |
Age Mean (SD) | 63 years (9.7) | 62 (9.6) | 68 (9.8) | P < 0.0001 |
CCS I | 124 (10%) | 107 (11%) | 17 (11%) | P = 0.01 |
II | 335 (29%) | 307 (30%) | 28 (18%) | |
III | 429 (36%) | 373 (36%) | 56 (35%) | |
IV | 289 (25%) | 231 (23%) | 58 (36%) | |
Previous MI | 552 (47%) | 457 (45%) | 95 (60%) | P = 0.01 |
Prev Cardiological Intervention | 87 (7.4%) | 78 (7.7%) | 9 (5.7%) | P = 0.42 |
Diabetes | 203 (17%) | 162 (16%) | 41 (26%) | P = 0.003 |
Hypertension | 573 (49%) | 487 (48%) | 86 (54%) | P = 0.012 |
Hypercholestrolemia | 843 (71%) | 749 (74%) | 94 (59%) | P < 0.0005 |
Current smoker | 73 (6.2%) | 62 (6.1%) | 11 (6.9%) | P = 0.723 |
COPD | 36 (3.1%) | 23 (2.3%) | 13 (8.2%) | P < 0.0005 |
PVD | 146 (12%) | 110 (11%) | 36 (23%) | P < 0.0005 |
Coronary Disease | ||||
Single | 56 (4.8%) | 54 (5.3%) | 2 (1.3%) | P = 0.860 |
Double | 258 (22%) | 234 (23%) | 24 (15%) | |
Triple | 863 (73%) | 730 (72%) | 133 (84%) | |
LMS disease | 202 (17%) | 173 (17%) | 29 (18%) | P = 0.734 |
EF Good | 777 (66%) | 701 (69%) | 76 (48%) | P < 0.0005 |
Fair | 308 (26%) | 253 (25%) | 55 (34%) | |
Poor | 92 (8%) | 64 (6%) | 28 (18%) | |
Pre-op IABP | 17 (1.4%) | 11 (1.1%) | 6 (3.8%) | P = 0.019 |
No of distal anastomoses | 3.24 (0.97) Range 1–6 | 3.24 (0.98) | 3.26 (0.91) | P = 0.844 |
Bypass time | 67 mins (25) | 66 mins (24) | 75 mins (32) | P = 0.002 |
X-Clamp time | 27 mins (11) | 27 mins (12) | 27 mins (10) | P = 0.769 |
BMI>30 | 307 (28%) | 259 (27%) | 48 (31%) | P = 0.190 |
Trasylol | 243 (21%) | 210 (21% | 33 (21%) | P = 1.000 |